Position in REGN
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$2,103,180,930
+$127,190,649 QoQ
Shares Held
2,722,071
+6.3% QoQ
Ownership
2.60%
of shares outstanding
% of Portfolio
0.55%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 99.4335930253105.ToString("F0")%
Shared 0.ToString("F0")%
None 0.5664069746894919.ToString("F0")%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026FRANKLIN RESOURCES INC holds $7,056,412,222 across 165 Biotechnology names. REGN ranks #1 (29.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
This page
|
2,722,071 | $2,103,180,930 | |
| 2 | ASND |
Ascendis Pharma A/S
|
2,051,948 | $469,342,063 | |
| 3 | INSM |
INSMED Inc
|
2,617,251 | $427,972,880 | |
| 4 | JAZZ |
Jazz Pharmaceuticals plc
|
1,958,940 | $370,337,604 | |
| 5 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
551,132 | $246,102,477 | |
| 6 | BBIO |
BridgeBio Pharma, Inc.
|
2,438,925 | $181,114,568 | |
| 7 | ARGX |
Argenx SE
|
233,493 | $170,508,261 | |
| 8 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
470,390 | $155,637,935 |
All Filings in REGN
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,103,180,930 | 2,722,071 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $1,975,990,281 | 2,560,004 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $1,379,328,710 | 2,453,143 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $1,214,585,400 | 2,313,496 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $1,443,935,579 | 2,276,675 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $1,456,864,435 | 2,045,210 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $1,993,241,440 | 1,896,086 | Shares | Defined | 2024-11-27 | |
| 2024-06-30 | $2,021,237,889 | 1,923,102 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $1,630,744,877 | 1,694,298 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $425,191,603 | 484,113 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $397,662,496 | 483,210 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $351,124,627 | 488,664 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $402,440,815 | 489,784 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $363,250,728 | 503,473 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $362,481,321 | 526,197 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $310,157,629 | 524,686 | Shares | Defined | 2022-08-11 | |
| 2022-03-31 | $393,741,254 | 563,760 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $399,403,555 | 632,448 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $366,525,446 | 605,647 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $342,264,928 | 612,785 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $279,154,486 | 590,004 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $297,686,580 | 616,188 | Shares | Defined | 2021-02-10 | |
| 2020-09-30 | $403,342,197 | 720,537 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $432,653,442 | 693,744 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $284,607,145 | 582,865 | Shares | Defined | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||